These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 21953948)

  • 1. Balance measures for propensity score methods: a clinical example on beta-agonist use and the risk of myocardial infarction.
    Groenwold RH; de Vries F; de Boer A; Pestman WR; Rutten FH; Hoes AW; Klungel OH
    Pharmacoepidemiol Drug Saf; 2011 Nov; 20(11):1130-7. PubMed ID: 21953948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measuring balance and model selection in propensity score methods.
    Belitser SV; Martens EP; Pestman WR; Groenwold RH; de Boer A; Klungel OH
    Pharmacoepidemiol Drug Saf; 2011 Nov; 20(11):1115-29. PubMed ID: 21805529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propensity score balance measures in pharmacoepidemiology: a simulation study.
    Ali MS; Groenwold RH; Pestman WR; Belitser SV; Roes KC; Hoes AW; de Boer A; Klungel OH
    Pharmacoepidemiol Drug Saf; 2014 Aug; 23(8):802-11. PubMed ID: 24478163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calendar time-specific propensity score analysis for observational data: a case study estimating the effectiveness of inhaled long-acting beta-agonist on asthma exacerbations.
    Dilokthornsakul P; Chaiyakunapruk N; Schumock GT; Lee TA
    Pharmacoepidemiol Drug Saf; 2014 Feb; 23(2):152-64. PubMed ID: 24150874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma.
    Blanchette CM; Culler SD; Ershoff D; Gutierrez B
    Clin Ther; 2009 Nov; 31(11):2574-83. PubMed ID: 20110003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of inhaled corticosteroids in monotherapy or combined with long-acting {beta}2-agonists on mortality among patients with chronic obstructive pulmonary disease.
    Cyr MC; Beauchesne MF; Lemière C; Aaron SD; Blais L
    Ann Pharmacother; 2010 Apr; 44(4):613-22. PubMed ID: 20233915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
    Sobieraj DM; White CM; Coleman CI
    Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
    Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
    Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival with tiotropium compared to long-acting Beta-2-agonists in Chronic Obstructive Pulmonary Disease.
    Gershon AS; Wang L; To T; Luo J; Upshur RE
    COPD; 2008 Aug; 5(4):229-34. PubMed ID: 18671148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival among COPD patients using fluticasone/salmeterol in combination versus other inhaled steroids and bronchodilators alone.
    Mapel DW; Nelson LS; Lydick E; Soriano J; Yood MU; Davis KJ
    COPD; 2007 Jun; 4(2):127-34. PubMed ID: 17530506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people.
    Schramm TK; Gislason GH; Køber L; Rasmussen S; Rasmussen JN; Abildstrøm SZ; Hansen ML; Folke F; Buch P; Madsen M; Vaag A; Torp-Pedersen C
    Circulation; 2008 Apr; 117(15):1945-54. PubMed ID: 18378618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival of COPD patients using inhaled corticosteroids and long-acting beta agonists.
    Mapel DW; Hurley JS; Roblin D; Roberts M; Davis KJ; Schreiner R; Frost FJ
    Respir Med; 2006 Apr; 100(4):595-609. PubMed ID: 16199151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age and risks of FDA-approved long-acting β₂-adrenergic receptor agonists.
    McMahon AW; Levenson MS; McEvoy BW; Mosholder AD; Murphy D
    Pediatrics; 2011 Nov; 128(5):e1147-54. PubMed ID: 22025595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing treatment effects after adjustment with multivariable Cox proportional hazards regression and propensity score methods.
    Martens EP; de Boer A; Pestman WR; Belitser SV; Stricker BH; Klungel OH
    Pharmacoepidemiol Drug Saf; 2008 Jan; 17(1):1-8. PubMed ID: 17960554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukotriene antagonists as first-line or add-on asthma-controller therapy.
    Price D; Musgrave SD; Shepstone L; Hillyer EV; Sims EJ; Gilbert RF; Juniper EF; Ayres JG; Kemp L; Blyth A; Wilson EC; Wolfe S; Freeman D; Mugford HM; Murdoch J; Harvey I
    N Engl J Med; 2011 May; 364(18):1695-707. PubMed ID: 21542741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized controlled trial of adherence with single or combination inhaled corticosteroid/long-acting beta-agonist inhaler therapy in asthma.
    Perrin K; Williams M; Wijesinghe M; James K; Weatherall M; Beasley R
    J Allergy Clin Immunol; 2010 Sep; 126(3):505-10. PubMed ID: 20816187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Appropriate use of inhaled corticosteroid and long-acting beta(2)-adrenergic agonist combination therapy among asthma patients in a US commercially insured population.
    Ye X; Gutierrez B; Zarotsky V; Nelson M; Blanchette CM
    Curr Med Res Opin; 2009 Sep; 25(9):2251-8. PubMed ID: 19622006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An application of propensity score matching using claims data.
    Seeger JD; Williams PL; Walker AM
    Pharmacoepidemiol Drug Saf; 2005 Jul; 14(7):465-76. PubMed ID: 15651087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease.
    Lee TA; Wilke C; Joo M; Stroupe KT; Krishnan JA; Schumock GT; Pickard AS
    Arch Intern Med; 2009 Aug; 169(15):1403-10. PubMed ID: 19667304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of risk factors and health outcomes among persons with asthma.
    Smith K; Warholak T; Armstrong E; Leib M; Rehfeld R; Malone D
    J Asthma; 2009 Apr; 46(3):234-7. PubMed ID: 19373629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.